H.R.9495, Department of Defense Appropriations Act, 2027, Medical research issues and Neurofibromatosis provisions
Literal federal measure citations: H.R.9495
2026 · 3rd Quarter (July 1 - Sep 30)
NEUROFIBROMATOSIS, INC., NORTHEAST
Filed by VAN SCOYOC ASSOCIATES.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 19, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- VAN SCOYOC ASSOCIATES
- Filing UUID
- 6b32742d-963a-4021-96bc-7d39481a78ec
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Medical research issues and Neurofibromatosis provisions, as follows: H.R.9495, Department of Defense Appropriations Act, 2027 H.R.9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.